Waleed Arafat, President of ISCO and Professor of Clinical Oncology at University of Alexandria, shared a post on LinkedIn:
“Great gathering at the gynecologic oncology meeting at Mansoura University.
I was happy to participate in a stimulating debate on the role of neoadjuvant treatment for ovarian cancer, discussing patient selection, surgical outcomes, and the evolving evidence supporting neoadjuvant chemotherapy followed by interval debulking surgery in appropriately selected patients.
The session provided an excellent opportunity for multidisciplinary exchange and highlighted the continuous efforts to improve outcomes for women with ovarian cancer.
Many thanks to the organizers, faculty, and colleagues for the insightful discussions and the warm hospitality. Looking forward to future collaborations and advancing gynecologic oncology care together.”
Waleed Arafat/ LinkedIn
Other articles about Ovarian Cancer on OncoDaily.
